Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF MAY 12,1999 PSA#2344

National Cancer Institute, Research Contracts Branch, PSAS, 6120 Executive Blvd, EPS/Room 638, Bethesda, MD 20892-7227

B -- ANALYSIS OF NCI OUTREACH COMMUNICATION STRATEGY SOL NCI-RFQ090098-NV DUE 052499 POC Debbie Moore, Purchasing Agent, 301-402-4509, Todd Cole, Contracting Officer, 301-402-4509 RFQ-NCI 90098-NV for "Analysis of NCI Outreach Communication Strategy," which was issued as a combined synopsis/solicitation in the Commerce Business Daily (CBDNet) on April 28, 1999, is amended to provide answers to questions raised by prospective offerors. Additionally, a deadline for any additional questions has been set for May 17, 1999 at 11:00 AM EST. After the foregoing deadline has passed, there is no guarantee that a timely response will be forthcoming prior to the due date of offers which is now changed to May 24, 1999 at 3:00 PM EST. The following questions were submitted to the NCI Purchasing Agent and answers immediately follow as designated: Question 1. What is the NCI organizational structure? How many divisions, departments, and departments make up the National Cancer Institute? ANSWER 1: The organizational structure, along with all organizational entities (divisions, branches, etc.), are available at http://www.nci.nih.gov/mab/orgchart.htm . The National Cancer Institute employs approximately 2,800 people. Question 2: Is all staff located at the Executive Boulevard address? If not, where are additional locations? Answer 2: Not all staff are located at the Executive Boulevard address. There are staff throughout the locales encompassing Frederick, MD (approximately 400 employees) and Bethesda, MD (approximately 2,400 employees). Question 3: Does NCI currently have a fully integrated, internal communications system of any kind? If so, what system is currently in place? Answer 3: Internal messages and communications are accomplished via e-mail and voice mail. In addition, communication is also accomplished through NIH interoffice mail. Question 4: How many products does NCI currently have? Answer 4: NCI is not oriented organizationally to being a product provider; however, cancer-related information is widely disseminated by NCI. It is for this reason that the analysis is necessary. The answer to this question shall be determined by the required analysis that is to be performed under this requirement. Within the CBD synopsis/solicitation, "C. Information Reporting" provides additional detail. Question 5: In reference to Background Information and Analyses, will the noted information be gathered by NCI personnel and provided to the consultant? Answer 5: Yes, NCI will provide the information to the Contractor after the anticipated award. NCI does not have the information consolidated at this time; however, collection and consolidation is not part of the requirement. Question 6: Will the Audience Analysis be gathered by NCI personnel and provided to the contractor? Answer 6: Yes, NCI will provide the audience analysis to the Contractor. Based on the information, the Contractor is required to "develop one or more models of the types of information that NCI should provide and what the NCI product lines might look like" (See C. Paradigm Development). Question 7: Who and at what rate will the Panel of Expert members be compensated? How many participation hours does the NCI recommend/anticipate for thePanel of Expert members per week or during the 6-month period? Does the NCI anticipate this team to be a standing committee (long-term)? The Contractor is required to recommend a panel of experts to NCI. If necessary, the National Cancer Institute will compensate any panel members without Contractor involvement. The number of meeting and subsequent hours of panel participation is not known at this time without the initial analyses that the Contractor is to perform. However, the number of hours to be performed by the Contractor (500 hours) encompasses the meeting time with the panel and all other activities to be performed. NCI does not anticipate a standing committee that will continue long-term. Previous CBD Cite: (W-118 SN325382) Posted 05/10/99 (W-SN329504). (0130)

Loren Data Corp. http://www.ld.com (SYN# 0011 19990512\B-0002.SOL)


B - Special Studies and Analyses - Not R&D Index Page